Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Current Insights in the Development of Efficacious Vaccines Against RSV

Frontiers in Immunology(2020)10.3389/fimmu.2020.01507Source: DataRank Database

Current Insights in the Development of Efficacious Vaccines Against RSV is a research paper published in Frontiers in Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 43 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access43 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 3.43)OA: goldTopics (49)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Laura Stephens ORCID,Kody Waldstein ORCID,Gisela Canedo-Marroquín ORCID,Steven M. Varga ORCID,Alexis M. Kalergis ORCID

Live enrichment

PubMed:32765520 OpenAlex:https://openalex.org/W3038101268

National Institutes of Health

Grant: 5R01AI124093-02

Balancing protection versus immunopathology by RSV-specific memory CD8 T cells

National Institutes of Health

Grant: 5T32AI007485-14

Predoctoral Training Program in Immunology

FWCI

3.43

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fimmu.2020.01507/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2020.01507/pdf

publisherhttps://www.frontiersin.org/article/10.3389/fimmu.2020.01507/full

journalhttps://doi.org/10.3389/fimmu.2020.01507

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32765520

Fields of Study

Respiratory viral infections researchAnimal Virus Infections StudiesViral gastroenteritis research and epidemiology0301 basic medicine03 medical and health sciences0303 health sciences

MeSH Terms

AdenoviridaeAnimalsClinical Trials as TopicHumansImmunity, CellularRespiratory Syncytial VirusesVaccines, AttenuatedVaccines, SyntheticViral Fusion ProteinsRespiratory Syncytial Virus InfectionsCD8-Positive T-LymphocytesVaccines, SubunitRespiratory Syncytial Virus VaccinesImmunity, Humoral

Keywords

MedicineImmunologyCoronavirus disease 2019 (COVID-19)VirologyInfectious disease (medical specialty)PathologyT cellsRespiratory Syncytial Virus InfectionsCD8-Positive T-LymphocytesVaccines, AttenuatedAdenoviridae03 Salud y bienestarRespiratory Syncytial Virus VaccinesantibodiesAnimalsHumansClinical Trials as TopicImmunity, CellularVaccines, SyntheticvaccinesRC581-607Immunity, HumoralRespiratory Syncytial VirusestreatmentsVaccines, Subunit03 Good Health and Well-beingRespiratory Syncytial VirusImmunologic diseases. AllergyViral Fusion Proteins

Sustainable Development Goals

SDG 0: Good health and well-being